
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-08-06-2014
 - Volume 10
 - Issue 8
 
Study Shows Capsugel's Capsules as Suitable Excipients in QbD-based Product Development and Manufacturing
Study provides first substantive reference data on key quality attributes of empty capsules
A recent 
QbD is gaining considerable acceptance throughout the pharmaceutical industry. The concept was designed to ensure the highest level of quality by establishing a robust understanding of products and process.
Hard capsules form a major component of pharmaceutical products. It is essential that the development and manufacturing of hard capsules follow QbD principles because of their impact on the final product’s quality and performance. CQA variabilities such as weight and moisture content, need to be understood and evaluated for their impact on design space for both product and process, to achieve the desired quality and performance every time.
The study demonstrated that Capsugel’s hard capsules meet the requirements for pharmaceutical product development in accordance with QbD principles. Based on 42 batches of capsules, produced over a two-year period, Capsugel’s capsules maintained in-specification performance for key CQAs such as dimensional characteristics and weight variability; sulfur dioxide, sulfated ash, lubricant levels, and water content; and disintegration time, using the automatic endpoint. Findings confirm that Capsugel capsules enable our customers’ products to meet all finished dosage form specifications within the defined design space for QbD-based development.
Source: 
Articles in this issue
over 11 years ago
Acute Need for Supply Chain Transparencyover 11 years ago
Metrics Contract Services Adopts New Name and Logoover 11 years ago
Steady Progress Toward Continuous Flow API Synthesisover 11 years ago
When Payers Refuse to Cover New Drugs, CMOs Take a Hitover 11 years ago
Catalent Issues Initial Public Offeringover 11 years ago
Moving Toward a Safer Supply Chainover 11 years ago
Hovione's API Facility in Cork, Ireland Passes FDA Inspectionover 11 years ago
Croda Obtains EXCiPACT Certification for Mevisa Siteover 11 years ago
SGS Life Science Services to Expand Shanghai FacilityNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





